Gene · 5087
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epidemiological and clinical characteristics of adult acute lymphoblastic leukemia patients in Chile: A single-center analysis. | Leuk Res Rep | 2024 | 38179336 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived TP53BP1, CD34, and PBX1 from human peripheral blood serve as potential biomarkers for the assessment and prediction of vascular aging. | Hereditas | 2024 | 38173016 | PubTator, text mining | PubMed |
| A distant global control region is essential for normal expression of anterior HOXA genes during mouse and human craniofacial development. | Nat Commun | 2024 | 38167838 | PubTator, text mining | PubMed |
| NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. | Redox Biol | 2024 | 38150994 | PubTator, text mining | PubMed |
| The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia. | Ann Hematol | 2024 | 38148344 | PubTator, text mining | PubMed |
| A human embryonic limb cell atlas resolved in space and time. | Nature | 2024 | 38057666 | PubTator, text mining | PubMed |
| Regulation of the STAT3 pathway by lupus susceptibility gene Pbx1 in T cells. | Mol Immunol | 2024 | 38056350 | PubTator, text mining | PubMed |
| Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory. | J Mol Diagn | 2024 | 37981088 | PubTator, text mining | PubMed |
| Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia. | Int J Lab Hematol | 2024 | 37929321 | PubTator, text mining | PubMed |
| CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy. | Ann Hematol | 2024 | 37917373 | PubTator, text mining | PubMed |
| MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. | Leuk Lymphoma | 2024 | 37902585 | PubTator, text mining | PubMed |
| Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis. | Mol Cancer Res | 2024 | 37889101 | PubTator, text mining | PubMed |
| A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment. | Blood Adv | 2024 | 37871327 | PubTator, text mining | PubMed |
| A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia. | Cancer | 2024 | 37819686 | PubTator, text mining | PubMed |
| Mesenchymal stem cells overexpressing PBX1 alleviates haemorrhagic shock-induced kidney damage by inhibiting NF-κB activation. | Biochim Biophys Acta Mol Cell Res | 2024 | 37673222 | PubTator, text mining | PubMed |
| RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations. | Genes Dis | 2024 | 37588191 | PubTator, text mining | PubMed |
| Ocular manifestations of congenital anomalies of the kidney and urinary tract (CAKUT). | Pediatr Nephrol | 2024 | 37468646 | PubTator, text mining | PubMed |
| Prognostic significance of Wilms' tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemia. | Front Oncol | 2023 | 38293695 | PubTator, text mining | PubMed |
| Securing access to a comprehensive diagnostic panel for children with suspected acute lymphoblastic leukemia: Results from the Mexico in Alliance with St. Jude "Bridge Project". | Front Oncol | 2023 | 38288107 | PubTator, text mining | PubMed |
| The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms. | Int J Mol Sci | 2023 | 38203290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5087/papers?page=7